Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for CNP and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for CNP and 80,000+ other tickers.
See exactly how CNP's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CNP and 80,000+ other tickers.
CenterPoint Energy, Inc. operates as a public utility holding enterprise across the United States, primarily through its Electric and Natural Gas divisions. The Electric segment manages power generation assets, alongside the transmission and distribution networks that supply electricity to consumers, and actively participates in the wholesale power market. Its Natural Gas segment delivers natural gas distribution services, provides home appliance maintenance and repair in Minnesota, and extends home repair protection plans to natural gas customers in Arkansas, Indiana, Mississippi, Ohio…
CNP's Q3 earnings are likely to benefit from grid investments, rising electricity demand and rate-base growth, while higher financing costs could offset gains.
Louisbourg Investments Inc. lowered its position in shares of CenterPoint Energy, Inc. (NYSE: CNP) by 45.1% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 17,760 shares of the utilities provider's stock after selling 14,574 shares during the quarter. Louisbourg Investments Inc.'s holdings in CenterPoint
CenterPoint (CNP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
COPENHAGEN, Denmark, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization for once-weekly TransCon CNP (navepegritide) in the European Union for the treatment of achondroplasia in children two years of age and older whose epiphyses are not closed. The final European Commission (EC) decision on Ascendis Pharma's Marketing Authorisation Application (MAA) is expected during Q4 2026.
HOUSTON--(BUSINESS WIRE)--CenterPoint Energy, Inc. (NYSE: CNP) has established October 21, 2026 as an Additional Interest Regular Record Date under the terms of its 2.0 percent Zero-Premium Exchangeable Subordinated Notes due 2029 (ZENS). Additional Interest of $5.39122 per ZENS note will be paid on November 4, 2026 to holders of record of the ZENS as of the close of business on the Additional Interest Regular Record Date. The payment of Additional Interest reflects cash distributed in respect.